España
India
Italia
대한민êµ
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
SI-BONE
SIBN
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$17.84
-0.16
-0.89%
At close: -
$17.84
0.00
0.00%
After Hours: 4:00 PM EDT
Get Report
Comment
Q4 2024 earnings tomorrow on Mon Feb 24th after the market close
Conference call scheduled tomorrow at 16:30 PM
Click to view the webcast
SI-BONE (SIBN) Forecast
News
Earnings
SI-BONE (SIBN) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for SI-BONE (NASDAQ:SIBN) Stock
SI-BONE Stock (NASDAQ: SIBN)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, January 16, 2025
Southwest Airlines, Silexion Therapeutics And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Avi Kapoor
Why Taiwan Semiconductor Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Monday, January 13, 2025
SI-BONE shares are trading higher after the c...
Benzinga Newsdesk
Intra-Cellular Therapies, Standard BioTools, SI-BONE And Other Big Stocks Moving Higher On Monday
Avi Kapoor
Needham Reiterates Buy on SI-BONE, Maintains ...
Benzinga Newsdesk
SI-BONE Sees Prelim. FY24 Worldwide Revenue $...
Benzinga Newsdesk
SI-BONE Sees Prelim Q4 Worldwide Revenue $48....
Benzinga Newsdesk
Wednesday, December 18, 2024
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
Wednesday, November 20, 2024
The Analyst Verdict: SI-BONE In The Eyes Of 4 Experts
Benzinga Insights
Needham Reiterates Buy on SI-BONE, Maintains ...
Benzinga Newsdesk
Wednesday, November 13, 2024
SI-BONE shares are trading lower after the co...
Benzinga Newsdesk
Truist Securities Maintains Buy on SI-BONE, R...
Benzinga Newsdesk
Needham Reiterates Buy on SI-BONE, Maintains ...
Benzinga Newsdesk
Tuesday, November 12, 2024
SI-Bone Sees FY24 Worldwide Revenue $165M-$16...
Benzinga Newsdesk
SI-BONE Q3 2024 GAAP EPS $(0.16) Beats $(0.24...
Benzinga Newsdesk
Earnings Scheduled For November 12, 2024
Benzinga Insights
Tuesday, November 05, 2024
SI-BONE Receives Transitional Pass-Through Pa...
Benzinga Newsdesk
Monday, October 14, 2024
Analyst Scoreboard: 4 Ratings For SI-BONE
Benzinga Insights
Truist Securities Maintains Buy on SI-BONE, L...
Benzinga Newsdesk
Thursday, October 10, 2024
SI-BONE, Inc. Announces First-In-Patient Proc...
Benzinga Newsdesk
Monday, September 16, 2024
Here's Why You Should Add Inogen Stock to Your Portfolio Now
Zacks
Friday, September 13, 2024
Can QGEN Stock Gain From the Expanded Bio-Manguinhos/Fiocruz Alliance?
Zacks
Wednesday, August 28, 2024
ILMN's TSO Comprehensive IVD Test Secures FDA Approval as CDx
Zacks
Tuesday, August 27, 2024
Insulet's Omnipod 5 Wins FDA Approval for Type 2 Diabetes
Zacks
Monday, August 26, 2024
SI-BONE Receives FDA Nod for Its TNT Implant System
Zacks
Tuesday, August 20, 2024
SI-BONE Receives 510(k) Clearance And FDA Bre...
Benzinga Newsdesk
Tuesday, August 06, 2024
Analyst Ratings For SI-BONE
Benzinga Insights
Morgan Stanley Maintains Overweight on SI-BON...
Benzinga Newsdesk
These Analysts Cut Their Forecasts On SI-BONE Following Q2 Results
Avi Kapoor
Truist Securities Maintains Buy on SI-BONE, L...
Benzinga Newsdesk
Needham Maintains Buy on SI-BONE, Lowers Pric...
Benzinga Newsdesk
Monday, August 05, 2024
SI-BONE Sees FY24 Revenue $165M-$167M Vs $165...
Benzinga Newsdesk
SI-BONE Q2 2024 GAAP EPS $(0.22) Beats $(0.28...
Benzinga Newsdesk
Monday, July 15, 2024
Morgan Stanley Maintains Overweight on SI-BON...
Benzinga Newsdesk
Tuesday, May 07, 2024
Morgan Stanley Maintains Overweight on SI-BON...
Benzinga Newsdesk
JMP Securities Reiterates Market Outperform o...
Benzinga Newsdesk
SI-BONE Launches iFuse Bedrock Granite Implan...
Benzinga Newsdesk
A Closer Look at 6 Analyst Recommendations For SI-BONE
Benzinga Insights
Needham Reiterates Buy on SI-BONE, Maintains ...
Benzinga Newsdesk
Monday, May 06, 2024
SI-BONE Updates FY24 Worldwide Revenue Guidan...
Benzinga Newsdesk
SI-BONE Q1 2024 GAAP EPS $(0.27) Beats $(0.32...
Benzinga Newsdesk
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
Wednesday, April 03, 2024
Needham Reiterates Buy on SI-BONE, Maintains ...
Benzinga Newsdesk
Thursday, March 28, 2024
Peeling Back The Layers: Exploring SI-BONE Through Analyst Insights
Benzinga Insights
Piper Sandler Initiates Coverage On SI-BONE w...
Benzinga Newsdesk
Tuesday, February 27, 2024
SI-BONE shares are trading lower after the co...
Benzinga Newsdesk
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
Morgan Stanley Maintains Overweight on SI-BON...
Benzinga Newsdesk
Beyond The Numbers: 4 Analysts Discuss SI-BONE Stock
Benzinga Insights
Cantor Fitzgerald Maintains Overweight on SI-...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
